-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of February 13, according to the Financial Associated Press, Ascletis Pharmaceuticals announced that it has submitted a marketing authorization application for ritonavir (100 mg film-coated tablet) to Germany, France, Ireland and the United Kingdom through its European agents
At the same time, Ascletis continues to negotiate cooperation with domestic and international companies, including large multinational pharmaceutical companies, on the commercial supply of ritonavir in China and globally
Oral ritonavir tablet is one of the pharmacokinetic enhancers of various oral antiviral drugs against viral protease and one of the components of oral antiviral drug Paxlovid (combination packaging of nematevir tablets + ritonavir tablets)